skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: autor: Nishiwaki, Y remover autor: Goto, Koichi remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer

Oxnard, G.R. ; Yang, J.C.-H. ; Yu, H. ; Kim, S.-W. ; Saka, H. ; Horn, L. ; Goto, K. ; Ohe, Y. ; Mann, H. ; Thress, K.S. ; Frigault, M.M. ; Vishwanathan, K. ; Ghiorghiu, D. ; Ramalingam, S.S. ; Ahn, M.-J.

Annals of oncology, 2020-04, Vol.31 (4), p.507-516 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

2
136O Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial
Material Type:
Artigo
Adicionar ao Meu Espaço

136O Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial

Ahn, M.-J. ; Yang, J. ; Yu, H. ; Saka, H. ; Ramalingam, S. ; Goto, K. ; Kim, S.-W. ; Yang, L. ; Walding, A. ; Oxnard, G.R.

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S115-S115 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

3
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting
Material Type:
Artigo
Adicionar ao Meu Espaço

An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting

Goto, K. ; Satouchi, M. ; Ishii, G. ; Nishio, K. ; Hagiwara, K. ; Mitsudomi, T. ; Whiteley, J. ; Donald, E. ; McCormack, R. ; Todo, T.

Annals of oncology, 2012-11, Vol.23 (11), p.2914-2919 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

4
Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations
Material Type:
Artigo
Adicionar ao Meu Espaço

Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations

Iwama, E. ; Sakai, K. ; Azuma, K. ; Harada, T. ; Harada, D. ; Nosaki, K. ; Hotta, K. ; Ohyanagi, F. ; Kurata, T. ; Fukuhara, T. ; Akamatsu, H. ; Goto, K. ; Shimose, T. ; Kishimoto, J. ; Nakanishi, Y. ; Nishio, K. ; Okamoto, I.

Annals of oncology, 2017-01, Vol.28 (1), p.136-141 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

5
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
Material Type:
Artigo
Adicionar ao Meu Espaço

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)

Nokihara, H. ; Lu, S. ; Mok, T.S.K. ; Nakagawa, K. ; Yamamoto, N. ; Shi, Y.K. ; Zhang, L. ; Soo, R.A. ; Yang, J.C. ; Sugawara, S. ; Nishio, M. ; Takahashi, T. ; Goto, K. ; Chang, J. ; Maemondo, M. ; Ichinose, Y. ; Cheng, Y. ; Lim, W.T. ; Morita, S. ; Tamura, T.

Annals of oncology, 2017-11, Vol.28 (11), p.2698-2706 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

6
Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study

Shimokawa, M. ; Nosaki, K. ; Seto, T. ; Ohashi, K. ; Morise, M. ; Fujiwara, Y. ; Sakakibara, J. ; Murakami, H. ; Yano, S. ; Satouchi, M. ; Matsumoto, S. ; Goto, K. ; Yoh, K.

Annals of oncology, 2019-04, Vol.30, p.ii66-ii66 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

7
Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project
Material Type:
Artigo
Adicionar ao Meu Espaço

Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project

Shimizu, K. ; Nakaya, N. ; Saito-Nakaya, K. ; Akechi, T. ; Yamada, Y. ; Fujimori, M. ; Ogawa, A. ; Fujisawa, D. ; Goto, K. ; Iwasaki, M. ; Tsugane, S. ; Uchitomi, Y.

Annals of oncology, 2012-08, Vol.23 (8), p.1973-1979 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

8
A phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial

Kinoshita, I. ; Goda, T. ; Watanabe, K. ; Maemondo, M. ; Oizumi, S. ; Amano, T. ; Hatanaka, Y. ; Matsuno, Y. ; Nishihara, H. ; Asahina, H. ; Harada, T. ; Goto, K. ; Isobe, H. ; Nishimura, M. ; Dosaka-Akita, H.

Annals of oncology, 2018-10, Vol.29, p.viii540-viii540 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

9
Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer

Naito, T ; Seto, T ; Takeda, K ; Goto, K ; Okamoto, I ; Nakagawa, K ; Ohba, T ; Murakami, H ; Takahashi, T ; Yamanaka, T ; Yamamoto, N

Lung cancer (Amsterdam, Netherlands), 2014-12, Vol.86 (3), p.339-343 [Periódico revisado por pares]

Oxford: Elsevier Ireland Ltd

Texto completo disponível

10
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer

GOTO, K ; SEKINE, I ; TAMURA, T ; OHE, Y ; KUNITOH, H ; YAMAMOTO, N ; NOKIHARA, H ; YOSHIDA, K ; SUGIURA, T ; MATSUI, K ; SAIJO, N ; NISHIWAKI, Y ; KAKINUMA, R ; KUBOTA, K ; MATSUMOTO, T ; OHMATSU, H ; NIHO, S ; KODAMA, T ; SHINKAI, T

British journal of cancer, 2004-08, Vol.91 (4), p.659-665 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (144)
  2. Revistas revisadas por pares (157)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (160)
  2. Anais de Congresso  (3)
  3. Book Chapters  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1995  (8)
  2. 1995Até2000  (20)
  3. 2001Até2006  (51)
  4. 2007Até2014  (39)
  5. Após 2014  (48)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.